Lincoln National Corp’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,959
Closed -$1.33M 344
2024
Q1
$1.33M Sell
13,959
-106
-0.8% -$10.1K 0.02% 433
2023
Q4
$1.07M Sell
14,065
-169
-1% -$12.9K 0.02% 442
2023
Q3
$986K Sell
14,234
-2,702
-16% -$187K 0.02% 410
2023
Q2
$1.6M Sell
16,936
-832
-5% -$78.5K 0.03% 306
2023
Q1
$1.47M Sell
17,768
-12,572
-41% -$1.04M 0.03% 297
2022
Q4
$2.26M Buy
30,340
+3,617
+14% +$270K 0.05% 204
2022
Q3
$2.21M Buy
26,723
+1,112
+4% +$91.9K 0.05% 194
2022
Q2
$2.44M Buy
25,611
+117
+0.5% +$11.1K 0.06% 185
2022
Q1
$3M Sell
25,494
-447
-2% -$52.6K 0.06% 163
2021
Q4
$3.36M Sell
25,941
-494
-2% -$64K 0.07% 148
2021
Q3
$2.99M Buy
26,435
+604
+2% +$68.4K 0.07% 158
2021
Q2
$2.68M Buy
25,831
+2,438
+10% +$252K 0.06% 175
2021
Q1
$1.96M Sell
23,393
-2,765
-11% -$231K 0.05% 195
2020
Q4
$2.39M Buy
26,158
+1,367
+6% +$125K 0.06% 158
2020
Q3
$1.98M Buy
24,791
+1,741
+8% +$139K 0.06% 167
2020
Q2
$1.59M Buy
23,050
+445
+2% +$30.8K 0.05% 180
2020
Q1
$1.42M Buy
22,605
+2,868
+15% +$180K 0.05% 161
2019
Q4
$1.54M Buy
19,737
+6,525
+49% +$507K 0.05% 185
2019
Q3
$969K Buy
13,212
+453
+4% +$33.2K 0.04% 230
2019
Q2
$786K Buy
+12,759
New +$786K 0.03% 242
2019
Q1
Sell
-7,587
Closed -$387K 519
2018
Q4
$387K Buy
7,587
+2,073
+38% +$106K 0.02% 303
2018
Q3
$320K Buy
5,514
+168
+3% +$9.75K 0.01% 348
2018
Q2
$259K Buy
5,346
+591
+12% +$28.6K 0.01% 397
2018
Q1
$221K Sell
4,755
-3,669
-44% -$171K 0.01% 428
2017
Q4
$316K Buy
+8,424
New +$316K 0.01% 483